ClinicalTrials.Veeva

Menu

Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density (AMH)

E

Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital

Status

Completed

Conditions

AMH
Diet Habit
Polycystic Ovary Syndrome
Ovarian Failure

Treatments

Diagnostic Test: hormone profile
Behavioral: Dietary Inflammatory Index

Study type

Observational

Funder types

Other

Identifiers

NCT06426771
02/10 28.02.2024

Details and patient eligibility

About

The aim of the study was to calculate the dietary inflammatory index, dietary phytochemical index and NRF nutrient density of the dietary pattern routinely consumed by women and to assess whether there is a difference between PCOS patients with high AMH levels and the group with low AMH levels.

Full description

There is currently growing interest in the relationship between lifestyle, reproductive health and fertility. Recent research emphasizes the influence of environmental and lifestyle factors such as stress, diet and nutritional status on reproductive health. Ovarian reserve refers to the number and quality of eggs and is an indicator of reproductive potential. Ovarian reserve is inversely proportional to the chronological age of the mother, which is the most important determinant of reproductive capacity and reproductive success. It has been shown that reproductive aging accelerates after the age of 35. Therefore, the assessment of ovarian reserve is an important step in both the evaluation and treatment of infertility. Markers of ovarian reserve include antral follicle count (AFC), which is determined by transvaginal ultrasound, and serum levels of various biomarkers such as anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol. Studies show that certain dietary patterns and the intake of certain nutrients are associated with endometriosis, ovarian reserve and egg quality, ovarian infertility and fertility. In addition, there is evidence that modifiable lifestyle factors, such as adherence to certain dietary habits and avoidance of environmental toxins, may also have positive effects on ovarian reserve. Recent studies have shown that women's nutritional status, body mass index and eating habits influence ovarian reserve.

The Dietary Inflammatory Index (DII) is an index developed to assess the impact of general dietary habits on inflammation. It is known that the dietary inflammatory index is high in chronic diseases associated with inflammation. The Phytochemical Index is a calculation based on the consumption of fruits high in phytochemicals, all vegetables except potatoes, legumes, whole grains and whole grain-containing foods, and oilseeds that provides information about the level of phytochemicals in the diet. The NRF Nutrient Density Index is a continuous function and represents an arithmetic combination of weighted variables. In this continuous function algorithm, the negative part (foods that should be restricted) is subtracted from the positive part (foods that should be consumed). In the calculation phase of this model, foods were scored according to their nutrient content per 100 kcal and per serving size. By calculating the nutrient density of the food consumed, the quality of the person's diet can be determined.

Based on this information, it was planned to compare these 3 nutritional indices in patients diagnosed with PCOS with an AMH level above 3.32 ng/ml, in the low ovarian reserve group without a PCOS diagnosis with an AMH level below 1.2 ng/ml and in normo-responder patients with an AMH level between these two values.

Enrollment

90 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between the ages of 18 and 40,
  • No underlying metabolic disease (type 2 diabetes, hypertension, diagnosed anemia),
  • Female patients with AMH levels in our hospital,
  • Participants attending the PCOS clinic and under the care of our hospital dietitian will be enrolled in the study.

Exclusion criteria

  1. Age < 18 and > 40 years;
  2. Menopause, pregnancy or breastfeeding in the last 6 months;
  3. Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary causes, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction, and adrenal disease),
  4. Pre-existing systemic or psychiatric illnesses
  5. Taking medication that affects carbohydrate or fat metabolism (contraceptive pills, metformin, antiepileptic drugs, antipsychotics, statins and fish oil);
  6. Certain nutritional therapies or hypocaloric diet in the last three months; supplementation with antioxidants, vitamins or minerals;
  7. Taking medications that can affect fluid balance, such as non-steroidal anti-inflammatory drugs, diuretics, etc.
  8. Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of impaired device activity.

Trial design

90 participants in 3 patient groups

Low AMH Levels-
Description:
AMH levels: those with low AMH levels (\<1.2 ng/ml): 30 participants
Treatment:
Behavioral: Dietary Inflammatory Index
Diagnostic Test: hormone profile
Normal AMH levels-
Description:
normal AMH levels (1.2-3.32 ng/ml): 30 participants
Treatment:
Behavioral: Dietary Inflammatory Index
Diagnostic Test: hormone profile
High AMH levels-
Description:
high AMH levels (\>3.32 ng/ml): 30 Participants
Treatment:
Behavioral: Dietary Inflammatory Index
Diagnostic Test: hormone profile

Trial contacts and locations

1

Loading...

Central trial contact

Yaprak Engin-Ustun; Mujde Can Ibanoglu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems